AASC Research

05/21/2025

Today on Clinical Trials Day, we’re celebrating 21 years of partnership with our amazing research participants! Thanks to your involvement, our clinical research has contributed to the approval of 44 medications that help people with respiratory and allergic conditions live healthier lives. We couldn’t do it without you!

03/06/2025

Our dedicated staff and patients made a significant impact on our latest chronic cough study. Their contributions were so valuable that Dr. Steven was invited to participate as a co-author with the world’s leading chronic cough researchers to report the data from the early-phase SOOTHE trial. We remain committed to participation in this area so we can help bring to market the first-ever treatment for chronic cough!

"Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized, Controlled Trial (RELIEF)." American Journal of Respiratory and Critical Care Medicine, 0(ja), pp. Keywords: chronic cough; cough; P2X3 receptor

01/02/2025

Today the FDA announced the approval of Amphastar’s generic albuterol inhaler. This represents the 40th allergy/asthma medication that the research arm of AASC and our patients have helped bring to market to expand the treatment options for allergic respiratory disease!

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company's Abbreviated New Drug Application ("ANDA") for ...

12/17/2024

There still are no really good treatments for chronic cough available. AASC is proud to have worked with four of the companies working in this area, including an actively running study with Nocion Therapeutics.

Las Vegas Nevada United States As per DelveInsight s assessment globally Chronic Refractory Cough pipeline constitutes 4 key companies continuously working towards developing 4 Chronic Refractory Cough treatment therapies analysis of Clinical Trials Therapies Mechanism of Action Route of Administrat...

05/20/2024

Thank you AASC Clinical Research staff!